I think it's going to be a slow year now that we've missed out on the Cat 3 code in the May meeting. There are a few potential catalysts that could produce upward movement in the SP.
June qtr — I'm hoping for some revenue using the misc code. Show us the misc code isn't useless. Push us back into the 30's. Not holding my breath though. Most are on free trials for the majority of this qtr as far as I understand. Dustin wasn't convincing re use of misc code IMO. Also, the customer needs to weigh up the fact that the misc code approval rate is low so they could be paying for the software but not getting much reimbursement. If EIQ is able to generate revenue using the misc code, it would strongly demonstrate the perceived value of the software IMO.
September — Hoping for Cat 3 code receipt and revenue using the misc code.
December — FDA approval for HF and revenue using Cat 3 code.
There's more news flow that could come, but earnings and earnings growth are what is going to move the SP.. and we have none right now. Possibly none reported until December.
It went to 37c recently on speculation alone. If we had some revenue, and FDA approval for HF we could push 50c+. Id' be happy with that. Next year is boom time if all goes well.
EIQ Price at posting:
27.5¢ Sentiment: Buy Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)